Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

by PVA_Admin | Dec 11, 2025 | Feature

Published: 2 December 2025 Saravana R. K. Murthy, Taisen Zhuang, Olivia Z. Jones, Yasmine Dakak, Michael Keidar, Aviram Nissan, and Jerome Canady.  Residual tumor cells left behind after surgery are a major cause of cancer local recurrence. The Canady Helios Cold...

Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins

by PVA_Admin | Dec 2, 2025 | Cold Plasma Publications, Publications

Canady Helios Cold Plasma Induces Non-Thermal (24 °C), Non-Contact Irreversible Electroporation and Selective Tumor Cell Death at Surgical Margins Saravana R. K. Murthy, Taisen Zhuang, Olivia Z. Jones, Yasmine Dakak, Michael Keidar, Aviram Nissan, and Jerome...

US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System

by PVA_Admin | May 7, 2024 | 2024 press Release, Press Release

US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasma™...

USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024

by PVA_Admin | Sep 22, 2023 | 2023 Press Release, Press Release

USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024 TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced and Biological Technological Sciences...

Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”

by PVA_Admin | Aug 2, 2023 | 2023 Press Release, Press Release

Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers” The First Cold Atmospheric Plasma Phase 1 Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer TAKOMA PARK, Md.–(BUSINESS...